Upgrade to SI Premium - Free Trial

BTIG Downgrades Teva Pharma (TEVA) to Neutral

January 18, 2018 1:42 PM
BTIG downgraded Teva Pharma (NYSE: TEVA) from Buy to Neutral.Analyst Timothy Chiang commented, "We lower our rating on TEVA shares ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Downgrades

Next Articles